Arch Venture Corp
Latest statistics and disclosures from ARCH Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VERV, ERAS, GOSS, DNLI, Q32 Bio, and represent 89.99% of ARCH Venture Management's stock portfolio.
- Added to shares of these 2 stocks: Q32 Bio (+$5.5M), CERO.
- Started 2 new stock positions in CERO, Q32 Bio.
- Reduced shares in these 1 stock: RVMD (-$93M).
- Sold out of its position in RVMD.
- ARCH Venture Management was a net seller of stock by $-83M.
- ARCH Venture Management has $80M in assets under management (AUM), dropping by -50.90%.
- Central Index Key (CIK): 0001274403
Tip: Access up to 7 years of quarterly data
Positions held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 8 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Verve Therapeutics (VERV) | 33.2 | $27M | 2.0M | 13.28 |
|
|
| Erasca (ERAS) | 28.4 | $23M | 11M | 2.06 |
|
|
| Gossamer Bio (GOSS) | 11.8 | $9.5M | 8.1M | 1.18 |
|
|
| Denali Therapeutics (DNLI) | 9.7 | $7.8M | 381k | 20.52 |
|
|
| Q32 Bio | 6.8 | $5.5M | NEW | 321k | 17.04 |
|
| Cero Therapeutics Holdings Class A Com (CERO) | 5.5 | $4.4M | NEW | 1.4M | 3.07 |
|
| Singular Genomics Systems In (OMIC) | 2.4 | $2.0M | 3.8M | 0.51 |
|
|
| Unity Biotechnology (UBX) | 2.1 | $1.6M | 1.0M | 1.64 |
|
Past Filings by ARCH Venture Management
SEC 13F filings are viewable for ARCH Venture Management going back to 2018
- ARCH Venture Management 2024 Q1 filed May 15, 2024
- ARCH Venture Management 2023 Q4 filed Feb. 14, 2024
- ARCH Venture Management 2023 Q3 filed Nov. 14, 2023
- ARCH Venture Management 2023 Q2 filed Aug. 9, 2023
- ARCH Venture Management 2023 Q1 filed May 15, 2023
- ARCH Venture Management 2022 Q4 filed Feb. 14, 2023
- ARCH Venture Management 2022 Q3 filed Nov. 10, 2022
- ARCH Venture Management 2022 Q2 filed Aug. 15, 2022
- ARCH Venture Management 2022 Q1 restated filed May 27, 2022
- ARCH Venture Management 2022 Q1 filed May 13, 2022
- ARCH Venture Management 2021 Q4 filed Feb. 14, 2022
- Arch Venture Corp 2020 Q3 filed Nov. 16, 2020
- Arch Venture Corp 2020 Q2 filed Aug. 12, 2020
- Arch Venture Corp 2020 Q1 filed May 6, 2020
- Arch Venture Corp 2019 Q4 filed Feb. 5, 2020
- Arch Venture Corp 2019 Q3 filed Nov. 12, 2019